Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Treatment of uveitis with endoplasmic reticulum aminopeptidase 1 (ERAP1) inhibitors

US Patent 12157891 · Granted Dec 3, 2024

Estimated economic value: $66,712,000

Assignee

Inventors

View full patent text on Google Patents →